Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
doi: 10.1016/j.diabres.2015.07.015 4 SunFWuSWangJGuoSChaiSYangZet al
Aamod Rao and the team are here to explain the science and guide you safely
The market is beginning to bifurcate into those developing dual and triple receptor agonists (GLP-1, GIP, and glucagon) to optimize outcomes and those developing multiple single pathway agonists, which ultimately cannot match the efficacy potential of the multifunctional approach
Until then, it remains restricted to clinical research settings
Immunoregulation in diabetic wound repair with a photoenhanced glycyrrhizic acid hydrogel scaffold
doi: 10.1093/europace/euy117 17
US$ 28.79
US$ 20.05
US$ 27.35
